ZAI LAB News

ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Nov 6 04:11 ET

ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 7 09:11 ET

ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 5 00:12 ET

ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-Q

Aug 6 19:18 ET

ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 6 08:36 ET

ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K

Jul 9 19:53 ET

ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 5 08:47 ET

ZAI LAB: (Revised) Next Day Disclosure Return

Jul 2 04:40 ET

ZAI LAB: Next Day Disclosure Return

Jun 27 09:08 ET

ZAI LAB: Next Day Disclosure Return

Jun 25 10:44 ET

ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-K

Jun 11 18:56 ET

ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 6 04:30 ET

ZAI LAB: INSIDE INFORMATION - CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVED XACDURO (SULBACTAM-DURLOBACTAM) FOR HOSPITAL-ACQUIRED AND VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY ACINETOBACTER BAUMANNII-CALCOACETICUS COMPLEX

May 20 00:10 ET

ZAI LAB: INSIDE INFORMATION - CHINA''S NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVED AUGTYRO (REPOTRECTINIB) FOR TREATMENT OF PATIENTS WITH ROS1-POSITIVE NSCLC

May 12 20:05 ET

ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-Q

May 8 19:12 ET

ZAI LAB: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 7 08:30 ET

ZAI LAB: PROXY CARD

Apr 29 19:01 ET

ZAI LAB: 2023 ESG REPORT

Apr 29 18:14 ET

ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FORM S-3

Apr 21 20:07 ET

ZAI LAB: OVERSEAS REGULATORY ANNOUNCEMENT - FILING OF PRELIMINARY PROXY STATEMENT AND PROXY FORM

Apr 21 20:00 ET